Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endogenous skin and cytosolic proteins refers to the collective group of proteins found within the layers of the skin and the internal environment of skin cells, such as keratinocytes and melanocytes. This term does not identify a single molecular target but rather a broad class of proteins—including keratins, serum albumin, and various cytosolic enzymes—that can interact with exogenous chemicals (OECD, 2023). In pharmacology and toxicology, these proteins are significant because they serve as carriers for haptens; small, reactive molecules that become immunogenic only after covalently binding to these endogenous proteins (NIH, 2022). This process, known as haptenization, is the critical first step in the development of allergic contact dermatitis and other delayed-type hypersensitivity reactions (Lepoittevin, 2006). Because this category encompasses thousands of distinct proteins with diverse biological roles, it is considered too non-specific to be a therapeutic target in the traditional sense. Instead, it is a focal point for assessing the skin sensitization potential of topically applied drugs and cosmetic ingredients.
Haptenization: The covalent binding of small reactive molecules (haptens) to nucleophilic sites on endogenous skin and cytosolic proteins to form a complete antigen capable of eliciting an immune response.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endogenous skin and cytosolic proteins.